Intervention With an Erythropoietin-Derived Peptide Protects Against Neuroglial and Vascular Degeneration During Diabetic Retinopathy

OBJECTIVE: Erythropoietin (EPO) may be protective for early stage diabetic retinopathy, although there are concerns that it could exacerbate retinal angiogenesis and thrombosis. A peptide based on the EPO helix-B domain (helix B-surface peptide [pHBSP]) is nonerythrogenic but retains tissue-protecti...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: McVicar, Carmel M., Hamilton, Ross, Colhoun, Liza M., Gardiner, Tom A., Brines, Michael, Cerami, Anthony, Stitt, Alan W.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Diabetes Association 2011
Ämnen:
Complications
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3198080/
https://ncbi.nlm.nih.gov/pubmed/21911748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db11-0026
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk